Latest Cash Management News

Hexima Limited reported a stable cash position of $1.55 million at quarter-end, with a modest $87,000 net cash outflow from operations. The biotech company continues to explore strategic opportunities while maintaining a strong funding runway.

Triton Minerals has initiated legal proceedings after a key payment default in its sale of Mozambique graphite assets, while advancing exploration at its new Aucu copper/gold project.

Reedy Lagoon Corporation has completed an extensive FineFraction soil sampling program across four gold prospects at Burracoppin, while seeking a farm-in partner for its iron project and maintaining a cautious cash position.

DTI Group has delivered the initial batch of hardware for the Adelaide Metro Trams PACIS upgrade, marking a key milestone in its transit technology contract. The company reported $1.6 million in receipts for the quarter, alongside a modest cash balance of $347,000.

Mindax Limited reported a $7.75 million equity raise in Q1 2025, maintaining a solid cash position with nearly six quarters of funding available despite ongoing exploration expenditures.

Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.

TMK Energy has successfully doubled the capacity of its Gurvantes XXXV pilot well project with three new wells, achieving record monthly gas production and securing $2.3 million in fresh capital to advance commercialisation.

InteliCare Holdings reported a net operating cash outflow of AUD 447,000 for Q1 2025 but remains confident in sustaining operations through active cash management and potential capital raises.

Dragon Mountain Gold Limited reports steady progress in refining exploration targets at its Avalon and Cawse Projects while evaluating new acquisitions, despite a modest cash balance of $212,000.

North Stawell Minerals Ltd reported a significant reduction in cash reserves for the quarter ending March 2025, highlighting a potential capital raising as exploration activities near completion.

FirstWave’s Q3 FY25 update reveals steady contract renewals alongside tighter cash reserves, as the cybersecurity firm advances strategic partnerships and operational efficiencies.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.